1
|
Barbosa ECD, Feitosa AM, Bortolotto LA, Guerra GM, Filho JCAF, Cestário EES, Yugar-Toledo JC, Pimentel R, Ferrari B, Aguiar R, Barroso WKS, Eibel B, Xia X, Poulter NR, Beaney T. May Measurement Month 2019: an analysis of blood pressure screening results from Brazil. Eur Heart J Suppl 2021; 23:B30-B32. [PMID: 34054363 PMCID: PMC8153193 DOI: 10.1093/eurheartj/suab019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The aim of this study is to describe the results of the May Month Measurement (MMM) campaign implemented in Brazil, in 2019. Questionnaire data were collected and three measures of blood pressure (BP) were performed. The sample consisted of 13 476 individuals, 58.2% were white, 60.8% were women. The average age was 46.3 (18.6) years. Of all 13 476 participants, 6858 (50.9%) had hypertension defined as a systolic BP ≥140 mmHg or a diastolic BP ≥90 mmHg or being on anti-hypertensive medication. Of those with hypertension, 68.8% were aware of their diagnosis, 65.3% were on antihypertensive medication, and 36.1% had controlled BP (<140/90 mmHg). In addition, of 4479 participants on anti-hypertensive medication, 55.2% had controlled BP. The use of anti-hypertensive medication was associated with higher systolic (P < 0.001) and diastolic BP (P < 0.001) and having diabetes with higher systolic BP (P < 0.001). Previous hypertension in pregnancy was associated with higher systolic (P = 0.038) and diastolic BP (P = 0.003), and smoking was associated with higher systolic BP (P < 0.001). Lastly, obese and overweight individuals showed significantly higher systolic (P < 0.001) and diastolic (P < 0.001) BP. The Brazilian MMM19 data demonstrate that strategies to increase awareness of hypertension and a better control of the risk factors are still needed.
Collapse
Affiliation(s)
- Eduardo Costa Duarte Barbosa
- Serviço de Hipertensão e Cardiometabolismo Hosp, São Francisco Sta Casa Porto Alegre.,Liga Hipertensão de Porto Alegre, Porto Alegre, Brasil
| | | | | | | | | | | | | | - Rodrigo Pimentel
- Instituição: Cardioart Avaliação Clínica e Assistência Médica LTDA
| | - Bruno Ferrari
- Faculdade de Medicina de Assis, Fema Assis, São Paulo
| | - Rodrigo Aguiar
- Instituição: Universidade Federal de São Carlos/SP-UFISCAR
| | | | - Bruna Eibel
- Liga Hipertensão de Porto Alegre, Porto Alegre, Brasil.,Instituto de Cardiologia/FundaçãoUniversitária de Cardiologia, Porto Alegre/RS, Brazil.,Centro Universitário FSG, Caxias do Sul/RS, Brazil, Department of Mathematics, Imperial College London, Huxley Building, South Kensington Campus, SW7 2AZ, UK
| | - Xin Xia
- Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK
| | - Neil R Poulter
- Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK
| | - Thomas Beaney
- Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.,Department of Primary Care and Public Health, Imperial College London, St Dunstan's Road, London W6 8RP, UK
| | | |
Collapse
|
2
|
Barbosa E, Eibel B, Feitosa ADM, Brandão AA, Bortolotto LA, Neves MFT, Martin JFV, Spinelli ACS, Cestário EES, Campana EMG, Toledo JCY, Póvoa RMS, Beaney T, Ster AC, Poulter NR, Mota-Gomes MA, Barroso WKS. May Measurement Month 2018: an analysis of blood pressure screening results from Brazil. Eur Heart J Suppl 2020; 22:H26-H29. [PMID: 32884462 PMCID: PMC7455292 DOI: 10.1093/eurheartj/suaa022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Hypertension is a pathology of high prevalence in the world. In Brazil, it is the main risk factor for the major cause of death in the country, coronary heart disease. The May Measurement Month Campaign in 2018 (MMM18) included a population with representation from all Brazilian states and reflects some of the characteristics of hypertension in Brazil. Questionnaire data were collected and three measures of blood pressure (BP) were performed. The sample consisted of 12 413 individuals, 59.1% were white, 51.3% were women. The average age was 54. ± 16.0 years. Diabetes was present in 11.6%, previous myocardial infarction in 5.9%, and previous stroke in 2.7%. Current smokers were 9.3% and 12.4% were regular drinkers. The average body mass index was 27.3 ± 4.5 kg/m2. After multiple imputations, 67.9% were hypertensive (>140/90 mmHg). Of the individuals who were not taking antihypertensive medication, 27.9% were hypertensive and of those taking antihypertensive medication, 40.3% were uncontrolled. Systolic BP increased with age. The MMM18 campaign demonstrated a large number of unknown hypertensives and a high rate of uncontrolled hypertension in Brazil, unfortunately in keeping with 2017 findings.
Collapse
Affiliation(s)
| | - Bruna Eibel
- Hypertension League, Porto Alegre, Brazil
- Post Graduation Program IC/FUC, Porto Alegre, Brazil
| | - Audes D M Feitosa
- Laboratory of Immunopathology Keizo Asami, Federal University of Pernambuco, Recife, Brazil
| | | | | | - Mario F T Neves
- Department of Clinical Medicine State, University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - José F V Martin
- Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo, Brazil
| | | | | | - Erika M G Campana
- Universidade Nova Iguaçu (UNIG), Nova Iguaçu, Rio de Janeiro, Brazil
| | - Juan C Y Toledo
- Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo, Brazil
| | - Rui M S Póvoa
- Universidade Federal de São Paulo, São Paulo, Brazil
| | - Thomas Beaney
- Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK
- Department of Primary Care and Public Health, Imperial College London, St Dunstan’s Road, London W6 8RP, UK
| | - Anca Chis Ster
- Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK
| | - Neil R Poulter
- Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK
| | - Marco A Mota-Gomes
- Department of Cardiology, CESMAC/Uncisal, Hospital do Coração de Alagoas, Maceió, Brazil
| | | |
Collapse
|